Ganciclovir Oresund Pharma 500 mg Pulver till koncentrat till infusionsvätska, lösning

Land: Sverige

Språk: svenska

Källa: Läkemedelsverket (Medical Products Agency)

Bipacksedel Bipacksedel (PIL)
15-12-2022

Aktiva substanser:

ganciklovirnatrium

Tillgänglig från:

Øresund Pharma ApS

ATC-kod:

J05AB06

INN (International namn):

ganciklovirnatrium

Dos:

500 mg

Läkemedelsform:

Pulver till koncentrat till infusionsvätska, lösning

Sammansättning:

ganciklovirnatrium 543 mg Aktiv substans

Receptbelagda typ:

Receptbelagt

Produktsammanfattning:

Förpacknings: Injektionsflaska, 5 st; Injektionsflaska, 1 st; Injektionsflaska, 10 st

Bemyndigande status:

Godkänd

Tillstånd datum:

2022-12-15

Bipacksedel

                                1
PACKAGE LEAFLET: INFORMATION FOR THE USER
GANCICLOVIR ORESUND PHARMA 500 MG POWDER FOR CONCENTRATE FOR SOLUTION
FOR INFUSION
ganciclovir
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor, pharmacist or
nurse.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.
-
If you get any side effects, talk to your doctor, pharmacist or nurse.
This includes any possible
side effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What Ganciclovir Oresund Pharma is and what it is used for
2.
What you need to know before you use Ganciclovir Oresund Pharma
3.
How to use Ganciclovir Oresund Pharma
4.
Possible side effects
5.
How to store Ganciclovir Oresund Pharma
6.
Contents of the pack and other information
1.
WHAT GANCICLOVIR ORESUND PHARMA IS AND WHAT IT IS USED FOR
WHAT GANCICLOVIR ORESUND PHARMA IS
Ganciclovir Oresund Pharma contains the active substance ganciclovir.
This belongs to a group called
anti-viral medicines.
WHAT GANCICLOVIR ORESUND PHARMA IS USED FOR
Ganciclovir Oresund Pharma is used to treat diseases caused by a virus
called cytomegalovirus (CMV)
in adults and adolescent patients 12 years and older who have a weak
immune system. It is also used
to prevent CMV infection after an organ transplant or during
chemotherapy in adults and children
from birth.
•
The virus can affect any part of the body. This includes the retina at
the back of the eye – this
means the virus can cause problems with eyesight.
•
The virus can affect anyone, but it is a particular problem in people
with a weak immune system.
In these people the CMV virus can lead to a serious disease. A weak
immune system may be
caused by other diseases (such as AIDS) or by medicines (such as
chemotherapy or
immunosuppressants).
2.
WHAT YOU NEED TO KNOW 
                                
                                Läs hela dokumentet
                                
                            

Dokument på andra språk

Bipacksedel Bipacksedel engelska 15-12-2022
Produktens egenskaper Produktens egenskaper engelska 15-12-2022
Offentlig bedömningsrapport Offentlig bedömningsrapport engelska 02-11-2022